A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 0-9 |

Kurzvorträge, dgpt 2014, 25.02.14.xls

Kurzvorträge
Die Vortragssprache richtet sich nach der Fachgesellschaft.
Calcium channels
Jörg Striessnig (Innsbruck)
First author
City, Country
Agonist evoked Ca2+ elevation in mast 314 Transporter
Birgitta Burckhardt (Göttingen)
First author
City, Country
severe leukopenia, strongly reduces ABCC11 transport activity in vitro cotransporter 3 (NaDC3) and of the organic anion transporter 1 (OAT1) Protein kinases
Tatiana Syrovets (Ulm)
First author
City, Country
pathway, G2 cell cycle arrest, and apoptosis in chemoresistant prostate cancer cells Cyclic Nucleotides
Slava Nikolaev (Göttingen)
First author
City, Country
characterization and first in vivo receptor-microdomain communication in cardiac hypertrophy Bacterial toxins
Jan Hengstler (Dortmund) and Wim Wätjen (Halle)
First author
City, Country
Enzyme-deficient C3-E174Q from C. cyclophilins and FK506-binding proteins for membrane translocation Clostridium difficile toxin B induces Clostridium perfringens TpeL toxin indicates a two-receptor model of clostridial glycosylating toxins Oxidative and radiation stress
Cornelia Dietrich (Mainz)
First author
City, Country
against genotoxic stress in the in vivo model organism C. elegans factor Nrf2 in kidney cells both in vitro Caenorhabditis elegans by baicalein derivatives Cardiovascular system
Justus Stenzig (Hamburg)
First author
City, Country
Effects of maternal PETN treatment of 468 Toxic substances and metabolism
Charlotte Esser (Düsseldorf) and Albert Braeuning (Tübingen)
First author
City, Country
cytochrome P450 1A1 yielding glutathione and protein adducts Formation of cytotoxic benzo[a ]pyrene- 183 Green tea and one of its constituents, 289 inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 Toxic substances
Helga Stopper (Würzburg)
First author
City, Country
Correlation between in-vivo and in- vitro combination effects of triazole fungicides in the adrenal gland and H295R cells Ludwigshafen, Testing mixtures in vivo at human- Velocity of the release of free cyanide 484 cyanogenic glycosides after tissue destruction as important factor determining their toxicity Small and heterotrimeric G proteins
Joachim Orth (Freiburg)
First author
City, Country
Enhanced sensitivity of phospholipase 293 lymphocytic leukaemia resistance to the Bruton´s tyrosine kinase inhibitor ibrutinib in vivo Pasteurella multocida toxin stimulates 217 osteoclast differentiation by activation Central nervous system
Marion Bankstahl (Hannover)
Immunopharmacology (I)
Martina Schmidt (Groningen, NL)
First author
City, Country
aeruginosa , a bacterium critical to cystic fibrosis patients PLAID, a novel form of human hereditary antibody deficiency and immune dysregulation Immunopharmacology (II)
Detlef Neumann (Hannover)
phosphate enhancesCOX-2 expression and migration in human monocytes remodeling processes induced by cigarette smoke GPCRs (I)
Martin Göttle, Hannover (Germany)
First author
City, Country
receptor binding in hematopoietic cells from rat spleen and bone marrow? Quantifying ligand bias of enantiopure 166 GPCRs (II)
Andreas Bock (Würzburg)
Genetic dissection of plexin signalling 165 Differential participation of Gβγ in the Clinical Pharmacology (I)
Jens Tank (Hannover)
First author
City, Country
and metabolism in obese hypertensive patients the worldwide genetic variability in the OCT1 gene? and mir-132. Results from a genomewide miRNA screen in focal and non-focal brain tissue of therapy-resistant epilepsy patients.
Clinical Pharmacology (II)
Renke Maas (Erlangen)
Eleutherococcus senticosus , radix, with respect to its safety in hypertensive patients improving medication safety in ambulatory care Mutagenesis, carcinogenesis and cancer
Gerhard Fritz (Mainz) and Nicole Schupp (Würzburg)
First author
City, Country
cellular senescence in human peritoneal mesothelial LP9 cells dynamics in human keratinocytes with distinctive effects on genotoxicity highly expressed genes which are characterized by topoisomerase IIα enrichment at promoters ErbB3 in the nucleus – mechanisms of 432 Implications for their carcinogenic mode of action methyltransferase (MGMT) in vitro and in colorectal cancer cells

Source: http://www.dgpt2014.de/app/download/8605289894/Kurzvortr%C3%A4ge,+DGPT+2014,+25.02.14.pdf?t=1393346684